Ovarian cancer study reveals hidden struggles of patients and caregivers

NCT ID NCT07035067

Terminated Knowledge-focused Sponsor: PeriPharm Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how platinum-resistant ovarian cancer affects the quality of life of patients and their caregivers in Canada. Researchers surveyed 24 patients and their caregivers using questionnaires to measure symptoms, daily challenges, and overall well-being. The goal was to better understand the real-life hurdles they face and highlight the need for more support.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could provide a clearer picture of the real-life challenges faced by patients and caregivers, helping to guide better support and future research.
What could go wrong: This is an observational study with no treatment being tested, so it won't directly improve outcomes. It was also terminated early with only 24 participants, limiting the strength of its findings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CAREGIVER BURDEN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Caregiver Burden ovarian cancer refractory malignant neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CAREGIVER BURDEN OVARIAN CANCER PATIENT BURDEN

Contacts and locations

Locations

PROxy Network, an initiative of PeriPharm Inc.

Montreal, Quebec, H2Y 1V3, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.